533 related articles for article (PubMed ID: 37377861)
1. Iron homeostasis imbalance and ferroptosis in brain diseases.
Long H; Zhu W; Wei L; Zhao J
MedComm (2020); 2023 Aug; 4(4):e298. PubMed ID: 37377861
[TBL] [Abstract][Full Text] [Related]
2. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.
Cerasuolo M; Di Meo I; Auriemma MC; Trojsi F; Maiorino MI; Cirillo M; Esposito F; Polito R; Colangelo AM; Paolisso G; Papa M; Rizzo MR
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298586
[TBL] [Abstract][Full Text] [Related]
3. Brain Iron Dyshomeostasis and Ferroptosis in Alzheimer's Disease Pathophysiology: Two Faces of the Same Coin.
Mezzanotte M; Stanga S
Aging Dis; 2024 Jun; ():. PubMed ID: 38913042
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Iron Homeostasis in the Central Nervous System and the Role of Ferroptosis in Neurodegenerative Disorders.
David S; Jhelum P; Ryan F; Jeong SY; Kroner A
Antioxid Redox Signal; 2022 Jul; 37(1-3):150-170. PubMed ID: 34569265
[No Abstract] [Full Text] [Related]
5. The key roles of organelles and ferroptosis in Alzheimer's disease.
Long HZ; Cheng Y; Zhou ZW; Luo HY; Wen DD; Gao LC
J Neurosci Res; 2022 Jun; 100(6):1257-1280. PubMed ID: 35293012
[TBL] [Abstract][Full Text] [Related]
6. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
Belaidi AA; Bush AI
J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
[TBL] [Abstract][Full Text] [Related]
7. Iron dyshomeostasis and ferroptosis in Alzheimer's disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD.
Zhang Y; Wang M; Chang W
Front Pharmacol; 2022; 13():983623. PubMed ID: 36188557
[TBL] [Abstract][Full Text] [Related]
8. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
[TBL] [Abstract][Full Text] [Related]
9. Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis.
Yadav VK; Choudhary N; Gacem A; Verma RK; Abul Hasan M; Tarique Imam M; Almalki ZS; Yadav KK; Park HK; Ghosh T; Kumar P; Patel A; Kalasariya H; Jeon BH; Ali AlMubarak H
Redox Rep; 2023 Dec; 28(1):2269331. PubMed ID: 38010378
[TBL] [Abstract][Full Text] [Related]
10. The role of ferroptosis as a regulator of oxidative stress in the pathogenesis of ischemic stroke.
Delgado-Martín S; Martínez-Ruiz A
FEBS Lett; 2024 Apr; ():. PubMed ID: 38676284
[TBL] [Abstract][Full Text] [Related]
11. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.
Wu L; Xian X; Tan Z; Dong F; Xu G; Zhang M; Zhang F
Mol Neurobiol; 2023 May; 60(5):2832-2850. PubMed ID: 36735178
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control.
Naidu SAG; Clemens RA; Naidu AS
J Diet Suppl; 2023; 20(2):312-371. PubMed ID: 35603834
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.
Sun Y; Xia X; Basnet D; Zheng JC; Huang J; Liu J
Front Aging Neurosci; 2022; 14():904152. PubMed ID: 35837484
[TBL] [Abstract][Full Text] [Related]
14. Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases.
Lei J; Chen Z; Song S; Sheng C; Song S; Zhu J
Front Cell Neurosci; 2020; 14():231. PubMed ID: 32848622
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Insights on Ferroptosis in Parkinson's disease.
Thapa K; Khan H; Kanojia N; Singh TG; Kaur A; Kaur G
Eur J Pharmacol; 2022 Sep; 930():175133. PubMed ID: 35792170
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
[TBL] [Abstract][Full Text] [Related]
17. Iron chelators as a therapeutic option for Alzheimer's disease-A mini-review.
Schreiner OD; Schreiner TG
Front Aging; 2023; 4():1234958. PubMed ID: 37602277
[TBL] [Abstract][Full Text] [Related]
18. New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.
Nuñez MT; Chana-Cuevas P
Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30347635
[TBL] [Abstract][Full Text] [Related]
19. Insight into the potential role of ferroptosis in neurodegenerative diseases.
Ji Y; Zheng K; Li S; Ren C; Shen Y; Tian L; Zhu H; Zhou Z; Jiang Y
Front Cell Neurosci; 2022; 16():1005182. PubMed ID: 36385946
[TBL] [Abstract][Full Text] [Related]
20. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
Viktorinova A; Durfinova M
Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
